Opportunity Information: Apply for PAR 15 320
Apply for PAR 15 320
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "U.S. India Collaborative Vision Research Program (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.867 Vision Research.
- This funding opportunity was created on Aug 6, 2015 and posted on Aug 6, 2015.
- Applicants must submit their applications by Nov 9, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- Eligible applicants include: Native American tribal governments (Federally recognized) Public and State controlled institutions of higher education City or township governments For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Small businesses Public housing authorities/Indian housing authorities State governments Independent school districts Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education County governments Native American tribal organizations (other than Federally recognized tribal governments).
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The U.S. India Collaborative Vision Research Program (R01) is a National Institutes of Health (NIH) funding opportunity aimed at supporting joint vision research projects led by a U.S.-based institution working in formal partnership with an institution in India. The central goal is to build strong, bilateral scientific collaborations that push forward research and technology relevant to blinding eye diseases, visual disorders, and related complications. In practical terms, the program is meant to fund high-quality research that helps the field better understand how vision-threatening conditions develop, and how they can be prevented, managed, or treated, while also laying the groundwork for lasting U.S.-India institutional and investigator-to-investigator relationships beyond the life of a single award.
This opportunity uses the NIH R01 mechanism, meaning it supports discrete, investigator-initiated research projects, but with the specific expectation that the science is genuinely collaborative and benefits from the U.S. and India partnership. The scientific scope is broadly framed around vision research (CFDA 93.867, Vision Research) and explicitly calls out relevance to blinding diseases and visual disorders, including complications that arise from these conditions. The FOA emphasizes advancing science and technology, which typically signals interest not only in basic and translational biology of the eye and visual system, but also in approaches that could improve diagnostics, therapeutics, prevention strategies, or other tools that meaningfully affect eye health outcomes.
The applicant organization must be U.S.-based. While an Indian institution partner is required for the collaboration, non-U.S. entities are not eligible to apply directly as the applicant, and NIH policy restrictions noted in the announcement indicate that foreign components are not allowed under this FOA. It also states that non-domestic components of U.S. organizations are not eligible. That means the formal NIH applicant and all supported components must remain within allowable U.S.-based structures, even though the program is designed around bilateral collaboration with India. Put simply, the collaboration is required, but the application must be submitted by an eligible U.S. institution under NIH rules described in the FOA.
Eligibility is broad on the U.S. side and includes many common applicant types across academia, government, and the nonprofit and private sectors. Eligible applicants listed include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including 501(c)(3) nonprofits and certain nonprofits without 501(c)(3) status), for-profit organizations other than small businesses, small businesses, and multiple levels of government (state governments, county governments, city or township governments, special district governments, and independent school districts). The announcement also highlights additional eligible categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), as well as faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and certain tribal entities. This breadth reflects NIH’s general openness to a range of organizational structures as long as they can carry out rigorous biomedical research and meet the program’s collaboration requirements.
From a funding perspective, the FOA is categorized as a discretionary grant opportunity in the health area, and it specifies no cost sharing or matching requirement. The listed award ceiling is $250,000, which indicates an upper limit provided in the source data for this announcement. Applicants would still need to build a budget consistent with NIH cost principles and the project scope, but the ceiling gives a practical sense of the scale NIH expected under this program. Because this is an R01 FOA, applicants would typically be expected to propose a well-developed research plan with clear aims, strong methodology, and a collaboration structure that is credible and productive across the U.S.-India partnership.
Key administrative details from the source data include the Funding Opportunity Number PAR-15-320, with the opportunity posted on August 6, 2015. The original and current closing date listed is November 9, 2017, and the archive date is December 10, 2017, meaning this particular FOA is no longer open for applications under those dates. The official NIH information page is provided in the announcement (http://grants.nih.gov/grants/guide/pa-files/PAR-15-320.html). For technical issues accessing or linking to the announcement, the contact listed is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Overall, this FOA was designed to use the R01 research grant mechanism to catalyze serious, sustained U.S.-India partnerships in vision research, with the explicit intent of generating advances that matter for preventing and treating blindness and other significant visual disorders, while also strengthening long-term collaborative capacity between the two countries’ scientific communities.
Frequently Asked Questions (FAQs)
What is the U.S.-India Collaborative Vision Research Program (R01)?
It is a National Institutes of Health (NIH) funding opportunity that supports joint vision research projects led by a U.S.-based applicant institution working in a formal partnership with an institution in India. The program is intended to strengthen bilateral scientific collaboration while advancing research and technology relevant to blinding eye diseases, visual disorders, and related complications.
What is the main goal of this grant opportunity?
The central goal is to build strong, two-way (bilateral) U.S.-India collaborations that move forward science and technology related to vision-threatening conditions. The program aims to fund research that improves understanding of how these conditions develop and how they can be prevented, managed, or treated, while also laying groundwork for lasting institutional and investigator partnerships beyond a single award.
What NIH funding mechanism does this program use?
This opportunity uses the NIH R01 mechanism. R01s support discrete, investigator-initiated research projects. Under this FOA, the R01 is specifically expected to be genuinely collaborative and to benefit from the U.S.-India partnership.
What scientific areas are within scope for this program?
The scope is broadly framed around vision research (CFDA 93.867, Vision Research) and explicitly includes work relevant to blinding eye diseases, visual disorders, and related complications. The FOA emphasizes advancing science and technology, which can include basic, translational, and technology-oriented approaches that could improve prevention, diagnostics, therapeutics, management strategies, or other tools that meaningfully affect eye health outcomes.
Does the research have to be collaborative between the U.S. and India?
Yes. The FOA is designed around a formal U.S.-India partnership and expects the science to be truly collaborative and strengthened by contributions from both sides.
Who is eligible to apply as the applicant organization?
The applicant organization must be U.S.-based. The FOA lists a broad range of eligible U.S. applicant types, including higher education institutions (public/state-controlled and private), nonprofits (including 501(c)(3) and certain nonprofits without 501(c)(3) status), for-profit organizations (including small businesses and for-profits other than small businesses), and many government entities (state, county, city/township, special district governments, and independent school districts).
Are Indian institutions allowed to apply directly to NIH under this FOA?
No. Non-U.S. entities are not eligible to apply directly as the applicant under this FOA. An Indian partner institution is required for collaboration, but the application must be submitted by an eligible U.S.-based institution.
Are foreign components allowed under this funding opportunity?
No. The FOA states that foreign components are not allowed. It also specifies that non-domestic components of U.S. organizations are not eligible. In practical terms, the NIH applicant and supported components must remain within allowable U.S.-based structures, even though a formal collaboration with an Indian institution is required.
What types of organizations are explicitly highlighted as eligible applicants?
In addition to the broad eligibility categories, the FOA highlights eligibility for organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). It also notes faith-based or community-based organizations, regional organizations, U.S. territories or possessions, and certain tribal entities.
Is cost sharing or matching required?
No. The opportunity specifies that there is no cost sharing or matching requirement.
What is the maximum award amount listed for this opportunity?
The source information lists an award ceiling of $250,000. Applicants would still be expected to propose a budget consistent with NIH cost principles and the proposed project scope, but the ceiling provides an upper limit indicated in the announcement data.
What is the CFDA number associated with this program?
The program is associated with CFDA 93.867 (Vision Research).
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number is PAR-15-320.
When was this opportunity posted, and what were the closing dates?
The opportunity was posted on August 6, 2015. The listed closing date is November 9, 2017 (shown as both original and current in the provided information). The archive date is December 10, 2017.
Is this funding opportunity still open for applications?
No. Based on the listed closing date (November 9, 2017) and archive date (December 10, 2017), this FOA is no longer open for applications under those dates.
Where can applicants find the official NIH announcement page?
The official NIH information page provided is: http://grants.nih.gov/grants/guide/pa-files/PAR-15-320.html
Who is the contact for technical issues with accessing or linking to the announcement?
For technical issues accessing or linking to the announcement, the contact listed is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
What type of grant is this categorized as?
The FOA is categorized as a discretionary grant opportunity in the health area.
What does NIH mean by expecting a "genuinely collaborative" project?
Based on the FOA description, it means the research should be designed so that the U.S. and India partnership materially strengthens the project, rather than being a nominal relationship. The collaboration is intended to build durable institutional and investigator-to-investigator relationships and generate outcomes that persist beyond the award period.
What kinds of outcomes is this program trying to produce?
The program aims to generate advances in understanding, prevention, management, and treatment of blinding eye diseases and visual disorders, while also increasing long-term collaborative capacity between U.S. and Indian scientific communities.
Browse more opportunities from the same category: Health
Next opportunity: Buddy Bison and Kids To Parks Task 1
Previous opportunity: Coastal California Gnatcatcher Habitat Use Study and Population Surveys at Marine Corps Air Station Miramar, California
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 15 320
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 15 320) also looked into and applied for these:
| Funding Opportunity |
|---|
| Pilot Services Research Grants Not Involving Interventions (R34) Apply for PAR 15 323 Funding Number: PAR 15 323 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Special Diabetes Program for Indians Community Directed Program Apply for HHS 2016 IHS SDPI 0001 Funding Number: HHS 2016 IHS SDPI 0001 Agency: Indian Health Service Category: Health Funding Amount: $6,500,000 |
| Alzheimers Disease Core Centers (P30) Apply for RFA AG 16 018 Funding Number: RFA AG 16 018 Agency: National Institutes of Health Category: Health Funding Amount: $900,000 |
| Minority HIV/AIDS Research Initiative (MARI) to Build HIV Prevention, Treatment and Research Capacity in Apply for RFA PS 16 001 Funding Number: RFA PS 16 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Building Genomic Sequencing Capacity in Kenya Apply for CDC RFA GH15 1636 Funding Number: CDC RFA GH15 1636 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Ethical, Legal and Policy Issues in HIV Research with Key Populations (R21) Apply for PAR 15 327 Funding Number: PAR 15 327 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Oral HIVacc Oral Mucosal Immunization Approaches for HIV Prevention (R01) Apply for RFA DE 16 006 Funding Number: RFA DE 16 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Ethical, Legal and Policy Issues in HIV Research with Key Populations (R01) Apply for PAR 15 328 Funding Number: PAR 15 328 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| A National Coalition to Enhance STD/HIV Prevention through Promotion of a Holistic Approach to Health and Wellness Apply for CDC RFA PS11 111205CONT15 Funding Number: CDC RFA PS11 111205CONT15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Short term Measurements of Improved Physical and Molecular Resilience in Pre clinical Models (R01) Apply for RFA AG 16 006 Funding Number: RFA AG 16 006 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| USAID/GHANA PEOPLE FOR HEALTH Apply for RFA 641 15 000009 Funding Number: RFA 641 15 000009 Agency: Ghana USAID Accra Category: Health Funding Amount: $3,710,000 |
| Centers of Research Translation (P50) Apply for RFA AR 16 001 Funding Number: RFA AR 16 001 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Strengthening HIV/AIDS Continuum of Care Services Apply for RFA 641 15 000010 Funding Number: RFA 641 15 000010 Agency: Ghana USAID Accra Category: Health Funding Amount: $18,500,000 |
| Nonhuman Primate Reagent Resource (U24) Apply for RFA AI 15 038 Funding Number: RFA AI 15 038 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| A Data Analysis and Coordinating Center (DACC) for Research Training and Career Development Activities (U24) Apply for RFA HG 15 025 Funding Number: RFA HG 15 025 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Health and Reducing Cardiometabolic Risk in Youth with Serious Emotional Disturbance and Young Adults with Severe Mental Illness (R01) Apply for RFA MH 16 600 Funding Number: RFA MH 16 600 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel Nucleic Acid Sequencing Technology Development (R43/R44) Apply for RFA HG 15 033 Funding Number: RFA HG 15 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19) Apply for PAR 15 330 Funding Number: PAR 15 330 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Impact Evaluation of Combination HIV Prevention Intervention in Botswana under PEPFAR Apply for RFA GH 16 002 Funding Number: RFA GH 16 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $8,729,606 |
| Strengthening and Expanding HIV/AIDS Surveillance, Prevention, Care and Support Services Targeting Vulnerable Populations in Ho Chi Minh City, Vietnam Apply for CDC RFA PS10 101705CONT16 Funding Number: CDC RFA PS10 101705CONT16 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 15 320", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
